Remdesivir ▸ Facts ▸ Comments ▸ News ▸ Videos
The WHO No Longer Recommends Remdesivir For COVID-19 Patients
Credit: Wochit News Duration: 00:39Published
FDA Approves Remdesivir to Treat COVID-19
Credit: Cover Video STUDIO Duration: 01:20Published
Remdesivir has little effect on COVID deaths: WHO
Credit: Reuters Studio Duration: 01:36Published
COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated
Credit: ANI Duration: 02:59Published
You Might Like
World Health Organization Rejects Antiviral Drug Remdesivir as Covid-19 TreatmentIn a review of several trials, the World Health Organization found that Gilead’s drug did not improve survival rates for patients nor did it help them recover.
F.D.A. Approves Remdesivir as First Drug to Treat Covid-19The move indicated that the drug had cleared more rigorous hurdles since it was given emergency authorization in May.
Also reported by •Reuters
WHO study shows Remdesivir does little to prevent COVID-19 deathsThe antiviral drug has been considered one of the most promising COVID-19 treatments and was among those given to President Trump when he was hospitalized for coronavirus treatment.
Remdesivir Fails to Prevent Covid-19 Deaths in Huge TrialAn antiviral widely used to treat hospitalized patients did not lower the mortality rate in a multinational trial.
President Trump’s COVID-19 treatment is usually reserved for more serious patientsPresident Trump has been treated with Remdesivir, the steroid Dexamethasone, and an experimental antibody therapy since testing positive for COVID-19. Some experts say those drugs are usually reserved..
Trump COVID-19 treatment: President had stakes in Regeneron and Gilead, makers of antibody cocktail, RemdesivirPresident Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., makers of COVID-19 treatments.
New report blames administration mismanagement, Gilead monopoly for shortages of COVID-19 drugA new report says some hospitals around the country did not get enough of a critical drug used for COVID-19 patients. The FDA approved the drug, Remdesivir, for emergency use in May. But the report..
Remdesivir and COVID-19: New data suggests the experimental drug can shorten how long people are sickAccording to new results from Gilead, new data shows 74% of patients treated with remdesivir had recovered by their 14th day of hospitalization.
Remdesivir, the First Coronavirus Drug, Gets a Price TagFederal health officials and Gilead Sciences have settled on priority distribution to Americans — and nonnegotiable pricing.
Fact check: China doesn't own patent for coronavirus treatment remdesivirA viral claim that China owns remdesivir's patent through an agreement with a multi-national public health organization called Unitaid is false.
Haphazard Rollout of Coronavirus Drug Frustrates DoctorsRemdesivir was shipped to small hospitals even as besieged medical centers were denied access.
How Remdesivir, New Hope for Covid-19 Patients, Was ResurrectedThe drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
Your Thursday BriefingCoronavirus, Remdesivir, Unemployment: Here’s what you need to know.
Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of RemdesivirNeither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive.
What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirusRemdesivir, a Gilead Sciences antiviral drug, is reportedly showing promise for the treatment of the coronavirus in clinical trials.